Researchers at the University of Chicago found the link between inflammation and a short fuse by:
- Scientists measured CRP and IL-6 levels in the blood of 197 physically healthy volunteers.
- Of the group, 69 had been diagnosed with intermittent explosive disorder
- 61 with non-aggressive psychiatric disorders.
- While 67 had no mental problems.
Scientists found "a powerful indication" of a link between inflammation and a bad temper but researchers confessed they were unable to work out which one triggers the other.
Lead scientist Professor Emil Coccaro, from the University of Chicago, who oversaw the research explained:
A bad temper could be cured with an aspirin, say researchers in the US who have found that outbursts of anger may be linked to inflammation in the body.
Inflammation, when a part of the body swells because of harmful stimuli, was found to be greater in those with a psychiatric condition called "intermittent explosive disorder", or IED, say scientists.
They found more inflammation markers in the blood of those with very short fuses when compared to calmer people.
The research raises the possibility of anti-inflammatory drugs such as aspirin could be used as a literal "chill pill" to calm people down.
Professor Peter M Rothwell is the leader of the Oxford University group that conducted research into cancer and aspirin.
He found that aspirin reduced the incidence of cancers in the short-term. He also found that the chance of cancer patients dying after four or five years was reduced.
Cancer Research UK who are already researching aspirin's role in cancer, say Professor Peter M Rothwell's findings justify the government giving patients advice about aspirin and cancer.
There is strong evidence that a daily dose of aspirin could prevent cancer and could stop it spreading in patients who already have cancer.
Three reports in the Lancet by Professor Peter M Rothwell at Oxford University show aspirin reduced the risk of a cancer death by 15 per cent compared with controls. This improved to a 37 per cent reduced risk of a cancer death for those on aspirin from five years and onwards.
They also found that aspirin reduced the risk of cancer spreading by 36 per cent, particularly in patients with colorectal cancer. In these cases the risk of cancer spreading was reduced by 74 per cent.